ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
Новый препарат очищает организм от инфицированных клеток без последующего увеличения вирусной нагрузки
Уменьшение резервуаров ВИЧ-инфицированных клеток позволит контролировать ВИЧ без необходимости пожизненного приема ВААРТ.
Boosted darunavir plus lamivudine matches three-drug regimen
A combination of darunavir/ritonavir and lamivudine was just as effective as the same combination plus tenofovir, according to 24-week results of the ANDES study presented last month by Professor Pedro Cahn at the 9th IAS Conference on HIV Science in Paris (IAS 2017). Darunavir boosted by ritonavir ...
PCPs Can Effectively Manage Hepatitis C Virus Care With New Drugs
Primary care providers (PCPs) and nurse practitioners (NPs) can safely and effectively manage care for patients with hepatitis C virus (HCV), using new drugs, according to a study published online August 7 in the Annals of Internal Medicine. ASCEND (A Phase IV Pilot Study to Assess Community-Based Treatment Efficacy ...
The Medicines Patent Pool Welcomes First Generic Dolutegravir-Combination to Receive Tentative Approval from U.S. Food and Drug Administration
The Medicines Patent Pool (MPP) welcomes its sublicensing partner Mylan’s announcement yesterday that it has received Tentative Approval from the U.S. Food and Drug Administration (USFDA) for generic versions of its combination product tenofovir disoproxil fumarate (TDF), lamivudine (3TC) and dolutegravir (DTG). Mylan signed a licence ...